Retraction Note: BMC Cancer (2022) 22:728
The Editors have retracted this article. After publication, the authors contacted the journal to request a correction to Fig. 2c, as the same images were used for EdU si-NC and EdU si-Lnc-NDRG1, and provided the raw data for validation. Further checks by the publisher found additional concerns:
Figure 5d MG63 si-NDRG1 + miR-96-5p inhibitor NC and si-NDRG1 + miR-96-5p inhibitor images (and the associated raw data) appear to overlap.
There appear to be several other instances of image overlap in the raw data files.
The Editors therefore no longer have confidence in the presented data.
Xi Chen, Hao Zhu, Guangxin Zhou and Zhen Wang agree to this retraction. None of the other co-authors have responded to any correspondence from the Editors about this retraction.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s12885-022-09833-5.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Wang, Z., Wei, Y., Zhu, H. et al. Retraction Note: LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p. BMC Cancer 23, 1119 (2023). https://doi.org/10.1186/s12885-023-11644-1
Published:
DOI: https://doi.org/10.1186/s12885-023-11644-1